SCHEMBL3935289

SCHEMBL3935289

CC[C@]1(C(=O)O)C=C[C@@H](N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7234181 1.00
Hydrochloric Acid SCHEMBL4422759 0.98
Hydrochloric Acid SCHEMBL4415134 0.98
Hydrochloric Acid SCHEMBL4415130 0.98
SCHEMBL7238749 0.71 APLNR (0.32)
SCHEMBL2208896 0.71 APLNR (0.32)
Hydrochloric Acid SCHEMBL4413762 0.69 THRB (0.32)
Hydrochloric Acid SCHEMBL4093852 0.69 THRB (0.32)
SCHEMBL2496632 0.66
SCHEMBL7511362 0.63 FFAR3 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007759-A1 RESOLUTION PROCESS SZÉGÉDI TUDOMANYEGYETEM (HU) 2009-01-15 WO claimed
US-6562861-B1 (1R,3R,4R,1'S)-(-)-(1'-acetylamino-2 '-ethyl)butyl-4-(aminoimino)methylaminocyclopentan-1-carboxylic acid was prepd. and tested in vitro as neuraminidase inhibitor (IC50 less-than 1.mu.M). Bactericides or viricides BIOCRYST PHARMACEUTICALS, INC. 2003-05-13 US claimed